Clinical Trial Update: Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases [NA]

View source ↗

Summary

A clinical trial evaluating EVM18001 for refractory autoimmune diseases is currently recruiting, including systemic lupus erythematosus, systemic sclerosis (scl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis
• Systemic Lupus Erythematosus
• Systemic Sclerosis

Drugs mentioned

• EVM18001

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: System Lupus Erythematosus(SLE), Scleroderma | NA | Status: RECRUITING